{
     "PMID": "26546125",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160718",
     "LR": "20170220",
     "IS": "1471-2164 (Electronic) 1471-2164 (Linking)",
     "VI": "16",
     "DP": "2015 Nov 6",
     "TI": "Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA sponges.",
     "PG": "907",
     "LID": "10.1186/s12864-015-2160-6 [doi]",
     "AB": "BACKGROUND: Down syndrome (DS) or trisomy 21 is the result of a genetic dosage imbalance that translates in a broad clinical spectrum. A major challenge in the study of DS is the identification of functional genetic elements with wide impact on phenotypic alterations. Recently, miRNAs have been recognized as major contributors to several disease conditions by acting as post-transcriptional regulators of a plethora of genes. Five chromosome 21 (HSA21) miRNAs have been found overexpressed in DS individuals and could function as key elements in the pathophysiology. Interestingly, in the trisomic Ts65Dn DS mouse model two of these miRNAs (miR-155 and miR-802) are also triplicated and overexpressed in brain. RESULTS: In the current work, we interrogated the impact of miR-155 and miR-802 upregulation on the transcriptome of Ts65Dn brains. We developed a lentiviral miRNA-sponge strategy (Lv-miR155-802T) to identify in vivo relevant miR-155 and miR-802 target mRNAs. Hippocampal injections of lentiviral sponges in Ts65Dn mice normalized the expression of miR-155 and miR-802 and rescued the levels of their targets methyl-CpG-binding protein 2 gene (Mecp2), SH2 (Src homology 2)-containing inositol phosphatase-1 (Ship1) and Forkhead box protein M1 (FoxM1). Transcriptomic data of Lv-miR155-802T miRNA-sponge treated hippocampi correlated with candidate targets highlighting miRNA dosage-sensitive genes. Significant associations were found in a subset of genes (Rufy2, Nova1, Nav1, Thoc1 and Sumo3) that could be experimentally validated. CONCLUSIONS: The lentiviral miRNA-sponge strategy demonstrated the genome-wide regulatory effects of miR-155 and miR-802. Furthermore, the analysis combining predicted candidates and experimental transcriptomic data proved to retrieve genes with potential significance in DS-hippocampal phenotype bridging with DS other neurological-associated diseases such as Alzheimer's disease.",
     "FAU": [
          "Bofill-De Ros, Xavier",
          "Santos, Monica",
          "Vila-Casadesus, Maria",
          "Villanueva, Eneko",
          "Andreu, Nuria",
          "Dierssen, Mara",
          "Fillat, Cristina"
     ],
     "AU": [
          "Bofill-De Ros X",
          "Santos M",
          "Vila-Casadesus M",
          "Villanueva E",
          "Andreu N",
          "Dierssen M",
          "Fillat C"
     ],
     "AD": "Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Rossello 149-153, 08036, Barcelona, Spain. Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain. Bioinformatics Platform, CIBERehd, Barcelona, Spain. Present address: Institute of Biology, Otto-von-Guericke University, Magdeburg, Germany. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Rossello 149-153, 08036, Barcelona, Spain. Bioinformatics Platform, CIBERehd, Barcelona, Spain. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Rossello 149-153, 08036, Barcelona, Spain. Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain. Bioinformatics Platform, CIBERehd, Barcelona, Spain. Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain. Cellular and Systems Neurobiology, Systems Biology Programme, Centre for Genomic Regulation (CRG), Universitat Pompeu Fabra, Barcelona, Spain. Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Rossello 149-153, 08036, Barcelona, Spain. cfillat@clinic.ub.es. Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain. cfillat@clinic.ub.es.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20151106",
     "PL": "England",
     "TA": "BMC Genomics",
     "JT": "BMC genomics",
     "JID": "100965258",
     "RN": [
          "0 (MicroRNAs)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Cell Line",
          "Down Syndrome/*genetics",
          "HeLa Cells",
          "Hippocampus/*metabolism",
          "Humans",
          "Mice",
          "MicroRNAs/*genetics"
     ],
     "PMC": "PMC4636806",
     "EDAT": "2015/11/08 06:00",
     "MHDA": "2016/07/19 06:00",
     "CRDT": [
          "2015/11/08 06:00"
     ],
     "PHST": [
          "2015/06/16 00:00 [received]",
          "2015/10/27 00:00 [accepted]",
          "2015/11/08 06:00 [entrez]",
          "2015/11/08 06:00 [pubmed]",
          "2016/07/19 06:00 [medline]"
     ],
     "AID": [
          "10.1186/s12864-015-2160-6 [doi]",
          "10.1186/s12864-015-2160-6 [pii]"
     ],
     "PST": "epublish",
     "SO": "BMC Genomics. 2015 Nov 6;16:907. doi: 10.1186/s12864-015-2160-6.",
     "term": "hippocampus"
}